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Abstract
Background—Although there is robust evidence linking childhood adversities (CAs) and an 
increased risk for psychotic experiences (PEs), little is known about whether these associations 
vary across the life-course and whether mental disorders that emerge prior to PEs explain these 
associations.
Methods—We assessed CAs, PEs and DSM-IV mental disorders in 23,998 adults in the WHO 
World Mental Health Surveys. Discrete-time survival analysis was used to investigate the 
associations between CAs and PEs, and the influence of mental disorders on these associations 
using multivariate logistic models.
Results—Exposure to CAs was common, and those who experienced any CAs had increased 
odds of later PEs (OR =2.3, 95%CI=1.9–2.6). CAs reflecting maladaptive family functioning 
(MFF), including abuse, neglect, and parent maladjustment, exhibited the strongest associations 
with PE onset in all life-course stages. Sexual abuse exhibited a strong association with PE onset 
during childhood (OR= 8.5, 95%CI=3.6–20.2), whereas other CA types were associated with PE 
onset in adolescence. Associations of Other CAs with PEs disappeared in adolescence after 
adjustment for prior-onset mental disorders. The population attributable risk proportion (PARP) 
for PEs associated with all CAs was 31% (24% for MFF).
Conclusions—Exposure to CAs is associated with PE onset throughout the life-course, although 
sexual abuse is most strongly associated with childhood onset PEs. The presence of mental 
disorders prior to the onset of PEs does not fully explain these associations. The large PARPs 
suggest that preventing CAs could lead to a meaningful reduction in PEs in the population.
Keywords
Psychotic experiences; childhood adversity; World Mental Health survey; maladaptive family 
functioning; discrete-time survival analysis; population attributable risk proportion
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Introduction
Psychotic experiences (PEs), including hallucinations and delusions, are common among the 
general population with a lifetime prevalence of 5.8% to 12.5% (Nuevo et al., 2010, Linscott 
and van Os, 2013, McGrath et al., 2015). Recent evidence indicates that exposure to 
childhood adversities (CAs) is associated with elevated risk of later PEs (Varese et al., 2012, 
Trotta et al., 2015, Morgan and Gayer-Anderson, 2016), with a meta-analysis reporting that 
CAs are associated with a 76% increased risk of PEs (Trotta et al., 2015).
Existing research on CAs and PEs is limited by a focus on specific types of CAs rather than 
a comprehensive set of CAs. For example, studies have reported mainly on the following 
types of CAs and risk of PEs: (a) sexual abuse (Read et al., 2003, Shevlin et al., 2007, 
Kilcommons et al., 2008, Bentall et al., 2012, Murphy et al., 2014, van Dam et al., 2015), (b) 
child abuse and neglect (Janssen et al., 2004, Arseneault et al., 2011, Kelleher et al., 2013, 
van Dam et al., 2015), and (c) bullying and peer victimisation (van Dam et al., 2012, 
Kelleher et al., 2013, Wolke et al., 2014, Cristobal-Narvaez et al., 2016).
CAs rarely occur in isolation (Green et al., 2010, Kessler et al., 2010, McLaughlin et al., 
2010b). The pathways linking CAs and subsequent mental health are also complex and inter-
correlated. For example, an association between parental mental illness and 
psychopathology in the offspring may be influenced by parenting ability (an ‘environmental’ 
exposure) as well as a range of confounding factors including shared genetic effects. CAs, 
like many traditional measures of environmental adversity, are modestly to moderately 
heritable (Kendler and Baker, 2007). Thus, we need more complex models that account for 
both the type and number of CAs are needed to determine whether the associations of CAs 
with PEs are specific to certain types of experiences but not others, and how increasing 
levels of exposure influence the risk for PEs. Indeed, several prior studies have documented 
a dose-response relationship between number of CAs and lifetime prevalence of PEs 
(Janssen et al., 2004, Shevlin et al., 2007, Wigman et al., 2011a, Wigman et al., 2011b, 
Bentall et al., 2012, Murphy et al., 2013, Muenzenmaier et al., 2015).
Moreover, while the evidence linking CAs and lifetime PEs is robust (Morgan and Gayer-
Anderson, 2016), little is known about the patterning of these associations at different stages 
of development. In particular, we are unaware of studies that have examined whether PEs 
tend to occur in close proximity to CA exposure, or whether CAs are associated with the 
onset of PEs at later periods in the life-course. PEs that emerge soon after CAs would 
suggest more direct and proximal mechanisms, consistent with stress-related mechanisms 
(CAs leads to a sensitization process that renders exposed individuals more reactive to 
subsequent stressors) (Cristobal-Narvaez et al., 2016). On the other hand, PEs that emerge 
many decades later might suggest indirect pathways, perhaps mediated by the occurrence of 
mental disorders. With regard to the latter possibility, extensive evidence suggests that CAs 
are associated with elevated risk of first onset of a wide range of mental disorders (Green et 
al., 2010, Kessler et al., 2010, McLaughlin et al., 2010b, McLaughlin et al., 2012). We 
recently demonstrated that most mental disorders are also associated with increased odds of 
subsequent PE onset (McGrath et al., 2016b). Thus, it seems reasonable to assume that the 
association between CAs and PEs may be mediated, at least in part, by the onset of mental 
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disorders following exposure to CAs. A recent analysis of the National Comorbidity Survey 
found that the associations of CAs with PEs were mediated partly by depression and/or 
anxiety (Sitko et al., 2014), although the temporal sequence of the association was not 
ascertained. Other research suggests that symptoms related to affective or emotional 
instability partially mediate the association between CAs and PEs (Bak et al., 2005, Kramer 
et al., 2012, Marwaha et al., 2014). Based on this initial work, there is a need for studies that 
explore the influence of mental disorders on the relationship between CAs and PEs. Ideally, 
these studies should explore a range of mental disorders, and ensure that the variables of 
interest are temporally-ordered (i.e. that CAs occur prior to onset of mental disorders, which 
occur prior to the onset of PEs), a necessary but not sufficient condition to infer causality.
Finally, prior work has estimated the population attributable risk proportions (PARPs) of 
mental disorders that are associated with CAs, and found sizable PARPs both in the U.S. and 
cross-nationally (e.g. 38–45% of childhood-onset mental disorders; and 28–29% of early-
adult onset mental disorders) (Green et al., 2010, Kessler et al., 2010). Estimates of PARPs 
related to psychotic experiences have also been derived from meta-analysis (33%) (Varese et 
al., 2012), but the relative importance of different types of CAs in contributing to the onset 
of PEs in the population remains unknown.
The aims of the present study were to examine the associations between CAs and first-onset 
of PEs, determine whether those associations vary at different stages of the life-course, and 
investigate the degree to which temporally-prior mental disorders explain the association 
between CAs and subsequent PE onset. We also estimated the population attributable risk 
proportion of PEs related to CA exposure. We used a large sample of adults drawn from a 
cross-national population-based study—the WHO World Mental Health (WMH) surveys.
Methods
Samples
The WMH surveys are a coordinated set of community surveys administered in probability 
samples of the general population in countries throughout the world 
(www.hcp.med.harvard.edu/WMH) (Kessler and Ustun, 2004). We examined 17 WMH 
surveys that included both the CIDI Psychosis Module and items related to CAs (n=23,998). 
These 17 countries are distributed across North and South America (Colombia, Mexico, 
Peru, Sao Paulo in Brazil, USA); Africa (Nigeria); the Middle East (Iraq, Lebanon); Asia 
(Shenzhen in the People’s Republic of China); and Europe (Belgium, France, Germany, 
Italy, the Netherlands, Portugal, Romania, Spain). All 17 surveys were based on multi-stage, 
clustered area probability sampling designs (Supplementary table S1). The weighted average 
response rate across all 17 countries was 71.9%.
In keeping with previous studies of PEs (Saha et al., 2011a, Saha et al., 2011b, McGrath et 
al., 2015, McGrath et al., 2016a, McGrath et al., 2016b), we made the a priori decision to 
exclude individuals with PEs who screened positive for possible schizophrenia/psychosis, 
and manic-depression/mania. Thus, we excluded respondents who (a) reported (1) 
schizophrenia/psychosis or (2) manic-depression/mania in response to the question “What 
did the doctor say was causing (this/these) experiences?”; or (b) reported lifetime use of an 
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antipsychotic medication for these symptoms. This resulted in the exclusion of 91 
respondents (0.4% of all respondents), leaving 23,998 respondents for this study (see 
Supplementary table S1).
Procedures
All surveys were conducted in the homes of respondents by trained lay interviewers. 
Informed consent was obtained before beginning interviews in all countries. Procedures for 
obtaining informed consent and protecting individuals (ethical approvals) were approved and 
monitored for compliance by the institutional review boards of the collaborating 
organisations in each country (Kessler and Ustun, 2008). Standardised interviewer training 
and quality control procedures were used consistently in the surveys. Full details of these 
procedures are described elsewhere (Kessler et al., 2006, Kessler and Üstün, 2008).
Interviews were administered in two parts to reduce respondent burden. Part 1 was 
administered to all participants and included the core diagnostic assessment of DSM-IV 
mental disorders. Part 2 of the interview included additional questions about PEs, correlates 
and other disorders was administered to respondents who met lifetime criteria for any Part I 
disorder and a random proportion of other respondents without any mental disorders. Part 2 
individuals were weighted by the inverse of their probability of selection to adjust for 
differential sampling, and therefore provide representative data on the target adult general 
population. Additional weights were used to adjust for differential probabilities of selection 
within households, nonresponse, and to match the samples to population socio-demographic 
distributions.
Data collection and Data items
The instrument used in the WMH surveys was the WHO Composite International Diagnostic 
Interview (CIDI) (Kessler and Üstün, 2008), a validated fully-structured diagnostic interview 
(http://www.hcp.med.harvard.edu/wmhcidi/instruments_download.php) designed to assess 
the prevalence and correlates of a wide range of mental disorders according to the definitions 
and criteria of both the DSM-IV and ICD-10 diagnostic systems. WHO translation, back-
translation, and harmonisation protocols were used to adapt the CIDI for use in each 
participating country.
Psychotic experiences (PEs)
The CIDI Psychosis Module included questions about 6 PE types – 2 related to hallucinatory 
experiences (visual hallucinations, auditory hallucinations) and 4 related to delusional 
experiences (thought insertion/withdrawal, mind control/passivity, ideas of reference, plot to 
harm/follow) (Supplementary table S2a, S2b). The respondents were asked if they ever 
experienced each PE (e.g., “Have you ever seen something that wasn’t there that other 
people could not see?”; “Have you ever heard any voices that other people said did not 
exist?” etc.). Only PEs occurring when the person was ‘not dreaming, not half-asleep, or not 
under the influence of alcohol or drugs’ were included. Respondents who reported PEs were 
then asked a probe question about the age of onset of PEs (i.e., How old were you the very 
first time (this/either of these things/any of these things) happened to you?).
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Childhood adversity
The WMH surveys assessed a range of family-related CAs (see Kessler et al, 2010). Eleven 
dichotomously scored CAs occurring before age 18 were assessed (full details are provided 
in Supplementary material S3). Age-of-exposure data were collected for other parental loss, 
parental divorce, parental death in the CIDI childhood section (eg. “How old were you when 
your father/mother died”), while the data on sexual abuse were collected using questions in 
the post-traumatic stress disorder section. As with previous analysis of CAs in the WMH 
surveys (Green et al., 2010, Kessler et al., 2010), we undertook an exploratory factor 
analysis via promax rotation (Supplementary Table S4), and confirmed that two meaningful 
groups of CAs were identified: (a) ‘Maladaptive Family Functioning’ (MFF) CAs, and (b) 
‘Other CAs’. Seven CAs loaded onto the MFF factor (parental mental illness, substance 
disorder and criminal behaviour, family violence, physical abuse, sexual abuse and neglect) 
and four CAs (parental death, parental divorce, other parental loss and economic adversity) 
loaded onto the Other CA factor. All subsequent analyses examined CAs grouped by MFF 
and Other CAs.
Mental disorders
The WMHS CIDI assessed lifetime history of 21 mental disorders including mood disorders 
(major depressive disorder, bipolar disorders); anxiety disorders (panic disorder, generalized 
anxiety disorder (GAD), specific phobia, social phobia, agoraphobia without panic, post-
traumatic stress disorder (PTSD), separation anxiety disorder (SAD) further divided into 
childhood SAD and adult separation anxiety disorder); behavior disorders (intermittent 
explosive disorder, attention deficit disorder, oppositional defiant disorder, conduct 
disorder); eating disorder (anorexia nervosa, bulimia nervosa, and binge eating disorder); 
and substance use disorders (alcohol abuse, alcohol dependence, drug abuse, and drug 
dependence). The disorders that require childhood onset (e.g., attention deficit disorder, 
oppositional defiant disorder, conduct disorder, separation anxiety disorder) were included in 
Part II and are limited to respondents in the age range 18–39 or 18–44 years (depending on 
site) because of concerns about recall bias among older respondents (Kessler et al., 2007). 
All other disorders were assessed for the full sample age range. Clinical reappraisal studies 
indicate that lifetime diagnoses based on the CIDI have good concordance with diagnoses 
based on blinded clinical interviews (Haro et al., 2006). In keeping with our previous 
research, standardised diagnostic hierarchy rules among the disorders assessed were applied 
where appropriate (Kessler et al., 2005, McGrath et al., 2016a).
Statistical Analysis
Discrete-time survival analyses with person-year as the unit of analysis was used to 
investigate the associations between CAs and PEs. A person-year (PY) dataset was created 
such that each year in the life of each respondent (up to and including the age of onset of PE 
or in those without PE, their age at interview) was treated as a separate observational record. 
Age-of-exposure date were available for sexual abuse, other parental loss, parental divorce 
and parental death, otherwise age 4 years was set as a default age-of-exposure, in keeping 
with previous analyses for CAs used in the WMH studies (Bruffaerts et al., 2010, Green et 
al., 2010). In all analyses, the temporal order required the onset of CAs to precede that of 
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PEs. We first estimated bivariate associations of CAs with PEs followed by a series of 
multivariate models: (a) M1 included all CAs simultaneously into the models without 
considering number of CAs (type model), (b) M2 used only number of CAs based on MFF 
and/or Other CAs (number model), and (c) M3 based on both type and number of CAs 
(multivariate interactive model). We also examined if there were gender differences in the 
associations between CAs and PEs. In order to choose a model for subsequent analyses, we 
examined both (a) model fitting measures (Bayesian Information Criterion [BIC], Akaike 
Information Criteria [AIC]) (Akaike, 1974, Schwarz, 1978), and (b) chi-square tests in order 
to compare the Odds Ratios between CA types and/or number indicators as predictors of 
PEs.
Next, we re-estimated associations based on the most informative model for PE onsets 
occurring in 4 life-course stages: childhood (4–12 years); adolescence (13–19 years); young 
adulthood (20–29 years); and later adulthood (30+ years). This allowed us to examine 
whether the associations of CAs with PE onset varied across the life-course. Then, we 
examined the strength and pattern of association between CAs and PEs when adjusted for 21 
temporally-ordered mental disorders (i.e. the mental disorder occurred after the CA age-of-
exposure but prior to the onset of PEs).
Finally, the population-attributable risk proportions (PARPs) were calculated based on the 
proportion of PE associated with the CA in the bivariate models. PARPs can be interpreted 
as the expected proportion of reduction in the outcome prevalence if CAs were eradicated 
(Cole and MacMahon, 1971, Rothman and Greenland, 2005). In order to assess the 
differential impact of three country level strata on PE risk, we conducted post-hoc analyses 
by including interaction terms between CAs, country income strata. Details of the country 
strata classification are published elsewhere (McGrath et al., 2015).
As the WMH data are both clustered and weighted, the design-based Taylor series 
linearization implemented in SUDAAN software was used to estimate standard errors and 
evaluate the statistical significance of coefficients. Survival coefficients were exponentiated 
and are reported as odds ratios (ORs). Significance tests were evaluated using .05-level two-
sided tests.
Results
Prevalence of CAs in those with and without PEs
More than one-third of respondents (n=10,015, 37.9%) reported exposure to at least one CA 
before age 18 years (Table 1). The prevalence of CA exposure among respondents with PEs 
was 59.8% compared to 36.6% in those with no PEs. Among respondents with PEs, there 
was wide variation in the frequency of exposure to specific types of CAs, with the highest 
prevalence reported for physical abuse (21.7%) followed by parental mental illness (17.3%). 
Among those with PEs, 19.7% had been exposed to three or more CAs, whereas the 
comparable proportion in those without PEs was 6.9%.
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The influence of type and number of CAs
Table 2 summarizes the associations between CAs and subsequent first onset of PEs using 
type and/or number of CAs in both bivariate and multivariate models. In the bivariate model, 
all CAs with the exception of parental death were significantly associated with increased 
odds of subsequent PEs. Respondents with exposure to any CA had twice the odds of 
subsequent onset PEs compared to respondents with no CAs (OR=2.3, 95%CI=1.9–2.6). 
The ORs ranged from 1.7–4.0 for MFF CAs and 1.4–1.9 for Other CAs, with the highest 
ORs associated with sexual abuse (OR=4.0, 95%CI=2.6–6.3) physical abuse (OR=2.8, 
95%CI=2.3–3.3), and parental criminal behaviour (OR=2.7, 95%CI=2.0–3.7).
In general, the ORs in the multivariate model that controlled for all CA types were smaller 
than in the bivariate model, due to the high co-occurrence of CAs (see M1 multivariate 
model, Table 2). In the multivariate model, the ORs for PEs associated with specific types of 
CAs varied significantly (χ210 = 52.8, p<.001). The CAs that remained significantly 
associated with PEs in this model were parental mental illness, parent criminal behaviour, 
physical and sexual abuse, parent divorce, and economic adversity. For these CAs, the 
adjusted ORs ranged from 1.7–2.7 for MFF CAs and 1.3–1.4 for Other CAs. The highest 
adjusted ORs (≥2) were found for sexual abuse (OR=2.7, 95%CI=1.7–4.2), physical abuse 
(OR=2.0, 95%CI=1.6–2.4), and parental mental illness (OR=2.0, 95%CI=1.6–2.3). We 
further examined whether there were gender differences in the associations of the latter three 
CAs with subsequent PE onset (data not shown). The sex-specific associations were similar 
for parental mental illness (females OR=1.9, 95%CI=1.5–2.4; males OR=2.0, 95%CI =1.4–
2.9). For physical abuse, the OR (95% CI) was somewhat higher for males (2.3, 1.7–3.0) 
compared to females (1.7, 1.3–2.3), whereas for sexual abuse, the OR was higher and 
significant for females ((2.7, 1.7–4.4) and lower and non-significant for males (1.7, 0.8–3.6).
In the model examining number of CAs only (i.e. exactly 1, exactly 2, three or more CAs), 
there was a monotonic increase in the odds of PEs in respondents exposed to a greater 
number MFF CAs, indicating a dose-response relationship between number of CAs and PEs. 
A similar pattern of increasing odds of PEs was observed as the number of Other CAs 
increased (see M2 multivariate model, Table 2).
When we examined more complex models using type and number simultaneously in the 
multivariate models (M3), the odds ratio associated with number of MFF and Other CAs 
were for the most part lower than 1.0, indicating a pattern of sub-additive interactions, 
whereby the incremental association of each additional CAs lessens in magnitude as the 
number of CAs increases. Taking into account the BIC and AIC as well as the pattern of 
findings across the models, we chose indicators only for type of MFF and Other CAs as the 
most informative model for subsequent analyses (Table 2, Model M1).
In summary, we observed that exposure to CAs is associated with an increased odds of 
subsequent onset of PEs, that different CA types vary in their association with subsequent 
PEs, and that there was a dose-response relationship between higher numbers of CA types 
and subsequent PEs.
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Associations between CAs and subsequent onset of PEs across four life-course stages
Table 3 shows the associations between CAs and subsequent onset of PEs in four life-course 
stages (see Model I). MFF CAs, as a set (i.e. when all MFF types were considered together), 
were associated with onset of PEs in all four life-course stages (childhood, adolescence, 
early adulthood, later adulthood), whereas Other CAs, as a set, were associated with PE 
onset only during adolescence. A test for variation in the ORs across life-course stages was 
significant for MFF CAs (χ221 = 39.8, p = .008), but not in Other CAs, (χ212 = 9.4, p = .66). 
When examining the associations of particular CA types with PE onset across the life-
course, only two MFF CAs (parental mental illness, physical abuse) were significantly 
associated with increased odds of subsequent PE onset across each of the four life-course 
stages. Across particular CA types, only sexual abuse showed significant variation across 
life-course stages with respect to subsequent PEs onset (χ23 = 15.2, p=.002). The highest 
OR for sexual abuse and PE onset was during childhood (4–12 years) (OR=8.5, 95%CI=3.6–
20.2), and further analyses confirmed that respondents exposed to sexual abuse were more 
likely to have their PE onset during childhood (4–12 years) compared to older years (13 and 
over; χ21 = 5.5, p = .019).
In summary, MFF CAs are associated with PEs in all life-course stages, whereas Other CAs 
are associated with PEs only in adolescence. Moreover, while MFF CAs are associated with 
PEs across all life-course stages, sexual abuse was more strongly associated with PEs that 
emerge during childhood (4–12 years).
Associations between CAs and PEs adjusting for mental disorders
Next, we examined the associations of CAs with PEs adjusting for mental disorders that 
were temporally-prior to the onset of PEs (Table 4). There were slight reductions in the ORs 
associated with particular CA types after adjusting for mental disorders (M4) compared to 
the unadjusted model (M1). However, the associations of both MFF CAs and Other CAs 
with PEs remained significant as a set after adjusting for mental disorders. We also 
examined the association of CAs with PEs within the subgroup of respondents without any 
mental disorders that were temporally-prior to the onset of PEs (M5). As a set, associations 
for MFF CAs remained significant with PEs, but the relationship became non-significant for 
Other CAs. Of interest, the OR (95%CI) for the relationship between sexual abuse and PEs 
was 6.7 (2.5–18.0).
Finally, we examined the role of temporally-prior mental disorders in the associations of 
CAs and PEs across life-course stages (Table 5). The pattern of findings was similar to the 
unadjusted life-course models, with one exception. As a set, MFF and Other CAs were no 
longer associated with PE onsets during adolescence after adjustment for temporally-prior 
mental disorders. The association between sexual abuse and PEs during childhood persisted.
In summary, the pattern of associations between CAs and subsequent PEs remained similar 
in models adjusted for mental disorders, apart from weakening of the association between 
MFF or Other CAs and PE onset in adolescence after accounting for temporally-prior mental 
disorders.
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Population attributable risk proportions between CAs and PEs
The overall PARP for PEs associated with CAs was 30.9% (Supplementary table S5) with 
most of this proportion attributable to MFF CAs (24%). With regard to individual CAs, 
physical abuse had the highest PARP (8.2%), followed by parental mental illness (6.9%).
Post-hoc analysis
We conducted an additional analysis to assess the differential impact of three country level 
strata on PEs risk using interaction terms between CAs and country strata. While the overall 
joint effect was significant (χ222 = 40.4, p=.001), we found that the pairwise estimates for 
individual CAs on PEs were all non-significant except for ‘economic adversity’ (data not 
shown). This particular CA was rarely reported in low income countries, leading to unstable 
and imprecise estimates. Otherwise, this exposure was also associated with comparable 
estimates in middle and high income strata countries.
Discussion
Based on the largest study of PEs and CAs to date, we confirmed that CAs are associated 
with a more than two-fold increased odds of subsequent first onset of PEs, which is similar 
but slightly higher than the pooled estimate from a recent systematic review (Trotta et al., 
2015). We also confirmed a dose-response relationship between higher numbers of CA types 
and odds of subsequent PEs, consistent with previous literature (Janssen et al., 2004, 
Wigman et al., 2011b, Kelleher et al., 2013, Muenzenmaier et al., 2015, van Dam et al., 
2015). Additionally, we contributed four novel findings: first, that CAs involving 
maladaptive family functioning were more strongly related to PEs than Other CAs; second, 
that CAs involving maladaptive family functioning were associated with onset of PEs across 
all stages of the life-course; third, that temporally-prior mental disorders appeared to explain 
the association of CAs with PE onset in adolescence, but not other life-course stages; and 
finally, that CAs involving maladaptive family functioning may account for nearly one-
quarter of all PE onsets in the population. We discuss each of these in turn.
First, we examined whether the association of CAs with PEs varied according to CA types. 
To date, prior research has neither included a wide range of CA types, nor used statistical 
models that acknowledged the inter-correlated nature of CAs. Although all CAs were 
associated with PEs when examined one-at-a-time, when examined together, only four CAs 
reflecting maladaptive family functioning (parental mental illness, parental criminal 
behaviour, physical abuse, and sexual abuse) and two Other CAs (parental divorce, 
economic adversity) remained associated with subsequent PEs.
Second, CAs involving maladaptive family functioning were associated with PE onsets in 
every stage of the life-course, whereas Other CAs were associated only with PEs in 
adolescence.
We have recently presented the age-of-onset curve for PEs – the median (interquartile range; 
IQR) was 26 (17–41) years, indicating that PEs commence across a surprisingly wide age 
range (McGrath et al., 2016b). Our findings suggest that Other CAs might increase the risk 
for PEs through mechanisms that have proximal consequences (Bentall et al., 2014, Morgan 
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and Gayer-Anderson, 2016). In contrast, maladaptive family functioning CAs appear to 
create a generalized diathesis for PEs that persists across the life-course. This diathesis could 
involve a variety of emotional, neurobiological, and cognitive processes that are influenced 
by CAs, including heightened vulnerability to stress (McLaughlin et al., 2010c), elevated 
emotional reactivity and poor emotion regulation skills (McLaughlin et al., 2010a, McCrory 
et al., 2011, McLaughlin et al., 2015, Heleniak et al., 2016), and deficits in cognitive control 
(DePrince et al., 2009). Each of these domains, in turn, has been proposed as mechanisms 
that may underlie PEs (Freeman et al., 2007, Bentall et al., 2009, Bentall et al., 2014, 
Morgan and Gayer-Anderson, 2016). CAs related to maladaptive family functioning may 
differentially lead to social deafferentation and social defeat (at the individual and/or family 
level), which has been linked to risk of PEs (Morgan and Gayer-Anderson, 2016). 
Identifying the precise mechanisms through which maladaptive family functioning CAs 
influence risk for PEs and determining why this vulnerability persists throughout the life-
course are key areas for future research.
Third, associations between CAs and PEs were largely unchanged in childhood and 
adulthood after adjustment for mental disorders that began prior to the onset of PEs. In 
contrast, CAs were no longer associated with PE onset in adolescence after accounting for 
prior-onset mental disorders. We have previously identified an association between mental 
disorder and PEs (McGrath et al., 2016a). Our findings suggest that prior mental disorders 
might be particularly important as a pathway to PEs in adolescence among youths with 
exposure to CAs. It is possible that the vulnerability factors that predispose to adolescent-
onset PEs also contribute to other early-onset mental disorders that emerge following 
exposure to CAs. With respect to vulnerability factors, we found that parental mental illness 
was associated with an increased odds of PEs. This finding, which could reflect shared 
genetic vulnerabilities and/or adverse environmental exposures (e.g. suboptimal parenting), 
is consistent with other studies that have reported an association between family history of 
mental disorder and lifetime prevalence of PEs (Kelleher and Cannon, 2010, Varghese et al., 
2011, Jeppesen et al., 2015). Alternatively, CAs might increase risk for this early-life variant 
of PEs only among individuals who developed psychopathology following CA exposure as 
has been shown in other disorders such as PTSD (Breslau et al., 2008, Koenen et al., 2008).
Sexual abuse exhibited a particularly strong association with PEs that emerge during 
childhood (4–12 years), with an 8.5 fold increased odds of PE emergence among 
respondents who were sexually abused. Clinicians and researchers have long been aware of 
the association between childhood sexual abuse and clinical psychotic disorders (e.g. 
schizophrenia) (Read et al., 2005, Cutajar et al., 2010), and thus the links between this 
exposure and PEs has been of interest (Morgan and Gayer-Anderson, 2016). Many studies 
have previously reported links between sexual abuse and PEs (Read et al., 2003, Shevlin et 
al., 2007, Bentall et al., 2012, Murphy et al., 2014, van Dam et al., 2015, Cristobal-Narvaez 
et al., 2016). Identifying mechanisms that explain this association is important for targeting 
interventions to prevent the onset of PEs in children who have been sexually abused (i.e. 
psychotherapy aimed at reducing psychological vulnerabilities). Our findings suggest that 
intervening mental disorders do not play a meaningful role in this pathway.
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Fourth, CAs were associated with a substantial proportion of PE onsets in the population, 
and the bulk of the population attributable risk involves maladaptive family functioning CAs. 
This suggests that—assuming the association of CAs with PEs is causal—that nearly one-
third of PEs could be prevented if exposure to CAs was eliminated or if interventions were 
developed that could mitigate the risk pathways linking CAs to PEs. Similarly high PARPs 
have been observed for other mental disorders associated with CAs (Green et al., 2010, 
Kessler et al., 2010, McLaughlin et al., 2012), underscoring the significance of CAs in 
shaping the distribution of psychopathology in the population.
The current study has several limitations which deserve comment. We excluded those who 
were screen-positive for possible psychotic disorders (based on self-report, use of 
antipsychotic medications to treat PEs). However, we did not have access to valid measures 
of clinical psychotic disorders in our sample, and thus it is feasible that a small proportion of 
respondents with clinical psychosis were included in the analyses. We also relied on 
retrospective reports about age of onset, which might have led to a recall bias. For some 
CAs, we were not able to determine an age of onset, and used a default of age 4 which is the 
standard earliest age of onset for disorders and exposures within the WMH studies. 
However, we note that several prospective studies have confirmed the association between 
CAs and subsequent PEs (Arseneault et al., 2011, Fisher et al., 2013, Kelleher et al., 2013, 
Rossler et al., 2014, Wolke et al., 2014). While we were able to explore a much wider range 
of CAs than previous studies, we focused on family-related exposures and we lacked 
information on childhood bullying. In light of the growing body of evidence linking this 
particular type of CA with PEs, this would be an important exposure to include in future 
studies (Kelleher et al., 2008, van Dam et al., 2012, Fisher et al., 2013, Wolke et al., 2014). 
We did not adjust for multiple comparisons in this study which may lead to inflation of Type 
I errors. In the current analyses we have focussed on PEs as a class only, however there is 
evidence to suggest that certain types of CAs (e.g. sexual abuse) may be linked to 
hallucinations more than delusions (Bentall et al., 2014). We plan to explore this research 
question in future studies
Conclusions
Based on the largest single study to date, our cross-national study confirms the association 
between CAs and the subsequent onset of PEs. CAs related to maladaptive family 
functioning are associated with PEs that emerge across the life span, and intervening mental 
disorders do not account for this finding. Childhood sexual abuse was strongly associated 
with PEs that emerged during childhood. While we have more than enough evidence linking 
CAs with adverse mental and physical health outcomes (Scott et al., 2010), the robust 
literature now linking CAs and PEs can provide important clues to etiopathogenesis of PEs 
and mental disorders (Heleniak et al., 2016). These, in turn, can inform clinically-targeted 
interventions designed to reduce the burden of mental disorders in those exposed to CAs 
(Bentall et al., 2014, Morgan and Gayer-Anderson, 2016).
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Refer to Web version on PubMed Central for supplementary material.
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